The effects of vitamin D binding protein-macrophage activating factor and colony-stimulating factor-1 on hematopoietic cells in normal and osteopetrotic rats

Blood

Volumn 88, Issue 8, 1996, Pages 2898-2905

  Benis, K Allison ^a   Schneider, Gary B ^a,b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b The Chicago Medical College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; MACROPHAGE ACTIVATING FACTOR; VITAMIN D BINDING PROTEIN;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HEMATOPOIETIC CELL; MACROPHAGE; NEUTROPHIL; NEWBORN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0029862489     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.8.2898.bloodjournal8882898     Document Type: Article

References (51)

1. 3 binding protein (group-specific component, Gc) is a precursor for the macrophage activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci USA 88:8539, 1991
2. Haddad J: Traffic, binding and cellular access of vitamin D sterols, in Peck WA (eds): Bone and Mineral Research Vol 5. Elsevier Science, Amsterdam, The Netherlands. 1987, p 291
3. Haddad J, Walgate J: 25-Hydroxyvitamin D transport in human plasma: Isolation and partial characterization of calcifidiol-binding protein. J Biol Chem 251:4426, 1976
4. Van Baelen H, Bouillon R, DeMoor P: Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem 255:2270, 1980
5. Haddad J: Human serum binding protein for vitamin D and its metabolites: Evidence that actin is the DBP binding component in human skeletal muscle. Arch Biochem Biophys 213:538, 1982
6. Daiger S, Schanfleld M, Cavalli-Sforza L: Human group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci USA 72:2076, 1975
7. 3. J Clin Endocrinol Metab 43:86, 1976
8. Coppenhaver D, Sollenne N, Bowman B: Post-translational heterogeneity of the human vitamin D-binding protein (group-specific component). Arch Biochem Biophys 226:218, 1983
9. Viau M, Constans H, Debray H, Montreuil J: Isolation and characterization of the o-glycan chain of the human vitamin D-binding protein. Biochem Biophys Res Commun 117:324, 1983
10. 3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of β-galactosidase of B cells and sialidase of T cells. J Immunol 151:2974, 1993
11. 3 binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages. J Immunol 147:273, 1991
12. Nijweide P, Scheven B, Visser J: Proliferation and differentiation of osteoclast progenitor cells and precursor cells, in: Cohn DV, Martin TJ, Meunier PJ eds: Calcium Regulation and Bone Metabolism: Bone and Clinical Aspects. Amsterdam, The Netherlands, Exerpta Medica, 1987, p 301
13. Ash P, Loutit J, Townsend K: Osteoclasts derived from haematopoietic stem cells. Nature 283:669, 1980
14. Schneider G, Relfson M: A bone marrow fraction enriched for granulocyte-macrophage progenitors gives rise to osteoclasts in vitro. Bone 9:303, 1988
15. Schneider G: Cellular specificity of the cure for osteopetrosis: Isolation of and treatment with pluripotent hemopoietic stem cells. Bone 6:241, 1985
16. Marks S: Pathogenesis of osteopetrosis of the ia rat: Reduced bone resorption due to reduced osteoclast function. Am J Anat 138:165, 1973
17. Schneider G: An evaluation of the phagocytic cells in the ia rat: Oxidative metabolism in monocytes and macrophages. J Reticuloendothel Soc 31:225, 1982
18. Schneider G, Relfson M, Ellis T: Qualitative defects in natural killer cell function in ia osteopetrotic rats. J Bone Miner Res 7:941, 1992
19. Popoff SN, Schneider GB: Conversion of the vitamin D binding protein to a macrophage activating factor: Associated defects in osteopetrotic mutations, in Norman AW, Bouillon R, Thomaseh M, (eds): Vitamin D - A Pluripotent Steroid Hormone: Structural, Molecular Endocrinology and Clinical Applications. 1994, New York, NY de Gruyter, p 693
20. 3 on bone resorption and natural immunity in osteopetrotic (ia) rats. J Bone Miner Res 9:585, 1994
21. Schneider G, Relfson M: Effects of interleukin-2 on bone resorption and natural immunity in osteopetrotic (ia) rats. Lymphokine Cytokine Res 13:335, 1994
22. Stanley E, Guilbert L, Tushinski R, Bartelmez S: CSF-1 a mononuclear phagocyte lineage-specific hemopoietic growth factor. J Cell Biochem 21:151, 1983
23. Tushinski R, Oliver I, Guilbert L, Tynan P, Warner J, Stanley E: Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28:71, 1982
24. Kodama H, Yamasaki A, Nose M, Niida S, Ohgame Y, Abe M, Kumegawa M, Suda T: Congenital osteoclast deficiency in the osteopetrotic (op/op) mouse is cured by injections of macrophage colony-stimulating factor. J Exp Med 173:269, 1991
25. Felix E, Cecchini M, Hofstetter W, Elford P, Stutzer A, Fleisch H: Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res 5:781, 1990
26. Sundquist K, Cecchini M. Marks SC Jr: CSF-1 injections improve but do not cure skeletal sclerosis in osteopetrotic (op) mice. Bone 16:39, 1995
27. Marks S, Wojtowicz A, Szperl M, Urbanowska E, MacKay C, Wiktor-Jedrzejczak W, Stanley E, Aukerman S: Administration of colony-stimulating factor-1 corrects some macrophage, dental and skeletal defects in an osteopetrotic mutation (toothless, tl) in the rat. Bone 13:89, 1992
28. Marks SC Jr, MacKay C, Jackson M, Larson E, Cielinski M, Stanley E, Aukerman S: The skeletal effects of colony-stimulating factor-1 in toothless (osteopetrotic) rats: Persistent metaphyseal sclerosis and the failure to restore subepiphyseal osteoclasts. Bone 14:675, 1993
29. Orchard PJ, Dahl N, Aukerman SL, Blazar BR, Key LL Jr: Circulating macrophage colony-stimulating factor is not reduced in malignant osteopetrosis. Exp Hematol 20:103, 1992
30. Hochman N, Wahl L, Sandberg A: Coexistence of defective and normal immunologic functions in lymphocytes and macrophages from osteopetrotic (op) rats. J Immunol 129:278, 1982
31. Popoff S, Jackson M, Koevary S, Marks S: Coexistence of reduced function of natural killer cells and osteoclasts in two distinct osteopetrotic mutations in the rat. J Bone Miner Res 6:263, 1991
32. Stechschulte J, Sharma R, Dileepan K, Spson K, Aggarwal N, Clancy J, Jilka R: Effect of the mi allele on mast cells, basophils, natural killer cells, and osteoclasts in C57BI/6J mice. J Cell Physiol 132:565, 1987
33. Beard C, Key L, Newberger P, Ezekowitz A, Arceci R, Miller B, Proto P, Ryan T, Anast C, Simons E: Neutrophil defect associated with malignant osteopetrosis. J Lab Clin Med 109:498, 1986
34. Reeves J, August C, Humbert J, Weston W: Host defense in infantile osteopetrosis. Pediatrics 64:202, 1979
35. Hochman N, Wahl L, Sandberg A: Coexistence of defective and normal immunologic functions in lymphocytes and macrophages from osteopetrotic (op) rats. J Immunol 129:278, 1982
36. Seifert M, Popoff S, Jackson M, MacKay C, Cielinski M, Marks SC Jr: Experimental studies of osteopetrosis in laboratory animals. Clin Orthop 294:23, 1993
37. Schneider G, Benis K, Flay N, Ireland R, Popoff S: Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. Bone 6:657, 1995
38. Schneider G, Reyes V, Benis A, Flay N, Marks S, Ireland S, Popoff S, Ando D: Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF), colony stimulating factor-1 (CSF-1) and the combination of these two factors on skeletal functions in two osteopetrotic mutations. J Bone Miner Res 9:S350, 1994 (suppl 1)
39. Spooncer E, Heywort CM, Dunn A, Dexter TM: Self-renewal and differentiation of interleukin 3 dependent multipotent stem cells are modified by stromal cells and serum factors. Differentiation 31:111, 1986
40. Yamamoto N, St. Claire D, Homma S, Ngwenya B: Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues. Cancer Res 48:6044, 1988
41. 3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells. Immunology 74:420, 1991
42. Stanley E, Hansen G, Woodcock J, Metcalf D: Colony stimulating factor and the regulation of granulopoiesis and macrophage production. Fed Proc 34:2272, 1975
43. Motoyoshi K, Takaku F, Mizoguchi H, Miura Y: Purification and some properties of colony-stimulating factor from normal human urine. Blood 52:1012, 1978
44. Felix R, Cecchini M, Fleisch H: Macrophage colony-stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127:2592, 1990
45. Nilsson SK, Lieschke GJ, Garcia-Winjnen CC, Williams B, Tzelepis D, Hodgson G, Grail D, Dunn AR, Bertoncello I: Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse. Blood 86:66, 1995
46. Begg SK, Betoncello I: The hematopoietic deficiencies in osteopetrotic (op/op) mice are not permanent, but progressively correct with age. Exp Hematol 21:493, 1993
47. Nilsson SK, Betoncello I: Age-related changes in extramedullary hematopoiesis in the spleen of normal and perturbed osteopetrotic (op/op) mice. Exp Hematol 22:377, 1994
48. Begg SK, Radley JM, Pollard JW, Chisholm OT, Stanley ER, Bertoncello I: Delayed hematopoietic development in osteopetrotic (op/op) mice. J Exp Med 177:237, 1993
49. Hume DA, Favot P: Is the osteopetrotic (op/op mutant) mouse completely deficient in expression of macrophage colony-stimulating factor? J Interferon Res 15:279, 1995
50. Schneider GB, Wolodko MA, Benis KA, Ray R, Swamy N, Baker AE, Jago RA, Popoff SN: Effects of vitamin D binding protein-macrophage activating factor on osteoclast and macrophage function in vitro. J Bone Miner Res (in press)
51. Phillips R, Lomnitzer R, Wadee A, Rabson A: Defective monocyte function in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 34:69, 1985